Original article
Surgical treatment of bronchogenic carcinoma: A retrospective study of 720 thoracotomies

https://doi.org/10.1016/S0003-4975(98)90009-1Get rights and content

Abstract

Seven hundred and twenty patients with primary bronchogenic carcinoma were operated on at the Pellenberg Clinic, K.U. Leuven, Belgium, between January 1, 1970, and January 1, 1985. Almost 45% of the resections were pneumonectomies and 47% were lobectomies. Mortality was 6.9% and 2.9%, respectively.

Patients with squamous cell carcinoma (Stages I and II) who underwent lobectomy or pneumonectomy had an absolute 5-year survival rate of 52.8% (93/176); it was 21% (4/19) in the T3 N0/N1 subgroup. Patients with adenocarcinoma who underwent a lobectomy had a 5-year survival rate of 49% (26/53) in the T1/T2 N0 group and of 27% (3/11) in the T1/T2 N1 group. Only 13.6% (3/22) of patients survived 5 years if a pneumonectomy had to be performed. Only 1 in 22 N2 patients survived 5 years after resection.

Cited by (56)

  • Routine surgical videothoracoscopy as the first step of the planned resection for lung cancer

    2009, Journal of Thoracic and Cardiovascular Surgery
    Citation Excerpt :

    Other authors, in a series of 650 patients with clinically staged resectable NSCLC, observed 7% of inoperable disease at thoracoscopy, mainly owing to pleural metastasis or direct invasion of vital structures.25 The rate of exploratory thoracotomies after conventional staging in the literature ranges from 3% to 25%.2-7 In a previous analysis of our experience of more than 2000 pulmonary resections carried out between 1967 and 1980, the rate of exploratory thoracotomy had been 19% but had decreased to 11.6% in the 1980s (1980–1991), after the progressive introduction of CT scanning in preoperative evaluation.8

  • What to do with "surprise" N2? Intraoperative management of patients with non-small cell lung cancer

    2008, Journal of Thoracic Oncology
    Citation Excerpt :

    The ability to deliver chemoradiotherapy seems to be poor, as discussed in the Effect of Exploration on Alternative Approaches section. The preponderance of data documents a much higher operative mortality than was assumed in the mathematical model.1–7 In addition, the actual data for outcomes are dependent on details of the patient cohort, as is discussed in this review.

  • Survival and outcomes of surgical treatment of the elderly NSCLC in China: A retrospective matched cohort study

    2007, European Journal of Surgical Oncology
    Citation Excerpt :

    There were conflicting data about the increasing age on the increasing incidence of major complication or postoperative death. A number of studies confirmed15–17 this observation and others18–20 did not found such relationship. Harvey et al.21 reported that significant increased operative mortality did not emerge until the age of 80 years.

  • Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition

    2005, Chest
    Citation Excerpt :

    In our study, the percentage of smokers in the elderly group was significantly higher than in the younger group, and this might have had some influence on the higher percentage of cases of squamous cell carcinoma in the elderly group. There was no difference in the TNM staging between the groups, although several previous studies16, 17, 18, 19, 20, 21 showed that elderly patients more often have earlier stages, likely due to the slow progress of lung cancer in the elderly, and the tendency of younger patients to ignore or misinterpret nonspecific changes in their health. In contrast to these results, one study11 conducted in Japan did not find a difference in the stage distribution, according to age.

View all citing articles on Scopus
View full text